Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Talk with a doctor about the right insulin for you and your lifestyle. Insulin is most commonly administered through a syringe, insulin pen ... increased activity, weight loss (if applicable ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

That medication has been available by prescription since 2019 for the treatment of Type 2 diabetes but is not FDA-approved for weight loss. GLP-1 pills can be a promising option for people with ...

By Gina Kolata and Rebecca Robbins A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and ...